Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)
TWD 16.15
(-9.01%)
TWD 16.15
(-9.01%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -103.61 Million TWD | -215.77% |
| 2022 | 109.07 Million TWD | 131.36% |
| 2021 | 47.14 Million TWD | 26.88% |
| 2020 | 33.09 Million TWD | -12.17% |
| 2019 | 42.3 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -16.65 Million TWD | -71.03% |
| 2024 Q2 | -18.67 Million TWD | -12.14% |
| 2023 Q1 | -14.76 Million TWD | -138.02% |
| 2023 Q4 | -9.73 Million TWD | 0.0% |
| 2023 FY | - TWD | -215.77% |
| 2023 Q2 | -14.76 Million TWD | 0.0% |
| 2023 Q3 | -9.73 Million TWD | 34.07% |
| 2022 Q3 | -6.2 Million TWD | 0.0% |
| 2022 FY | - TWD | 131.36% |
| 2022 Q4 | -6.2 Million TWD | 0.0% |
| 2021 FY | - TWD | 26.88% |
| 2020 FY | - TWD | -12.17% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -124.061% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 126.325% |
| Level Biotechnology Inc. | 98.7 Million TWD | 204.975% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -131.599% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -43.68% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -310.633% |
| GlycoNex Incorporation | -126.82 Million TWD | 18.302% |
| VBI | -6.97 Million TWD | -1386.159% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 27.892% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 575.08% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -484.537% |
| Visgeneer Inc. | 973 Thousand TWD | 10749.024% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 69.479% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 111.064% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 203.784% |
| Neith Corporation | -33.61 Million TWD | -208.286% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 89.545% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -5865.17% |
| Enimmune corporation | -228.96 Million TWD | 54.746% |
| TaiRx, Inc. | -208.64 Million TWD | 50.339% |
| CHO Pharma, Inc. | -277.73 Million TWD | 62.692% |
| EirGenix Inc. | -664.4 Million TWD | 84.405% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 240.202% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 249.856% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 90.329% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 8.391% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 397.419% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -66.207% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -293.973% |
| RBC Bioscience Corporation | 36.54 Million TWD | 383.512% |
| BiOptic Inc. | 65.03 Million TWD | 259.315% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 84.817% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -213.928% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -88.683% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 123.899% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -29.402% |
| NaviFUS Corp. | -55.79 Million TWD | -85.707% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -524.262% |
| Sinew Pharma Inc. | -163.63 Million TWD | 36.678% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -68.48% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 153.853% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 54.29% |
| AP Biosciences Inc | -325.51 Million TWD | 68.169% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 90.081% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -189.056% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 455.699% |
| Intech Biopharm Corporation | -219.58 Million TWD | 52.813% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 84.632% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -130.507% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 35.586% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 115.806% |
| TCI GENE Inc. | 25.98 Million TWD | 498.811% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 6.348% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 63.488% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 29.016% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 848.123% |
| PharmaEngine, Inc. | 347.3 Million TWD | 129.834% |
| Savior Lifetec Corporation | 219.6 Million TWD | 147.182% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 160.161% |
| OBI Pharma, Inc. | -855.08 Million TWD | 87.882% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -11.94% |
| Acepodia, Inc. | -764.51 Million TWD | 86.447% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 77.479% |